Roche melanoma drug wins European green light
by on Dec.16, 2011, under Health and Fitness
LONDON (Reuters) – European regulators have recommended approval of a targeted melanoma drug from Swiss group Roche Holding AG, opening the way to a new treatment option for patients with the deadliest form of skin cancer. The green light for Zelb…
View full post on Yahoo! Health News
